ICON expands US early phase research capabilities with new clinic and outpatient centres

Contributed by: Business Wire

Logo

Images

Welcoming visitors to ICON’s new San Antonio Phase 1 clinic, purpose‑built to support early clinical development

Business Wire embedded0

Tags

Consulting

Biotechnology

Professional Services

Managed Care

Health

Pharmaceutical

Medical Devices

Research

Hospitals

Science

Clinical Trials

Clinic

More Like This

ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research

ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer

ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability

ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023

ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report

ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies

Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON